PCA3 is a large-chain RNA molecule that is measured in urine sediment and compared to PSA mRNA levels to obtain a PCA3 score, but it has not been able to differentiate indolent versus aggressive PCa, and its capability in monitoring progression and reclassification may be limited. This evidence concerns the gene PCA3 and posterior cortical atrophy.